323 related articles for article (PubMed ID: 33908609)
21. Transcriptomic Profiles of Normal Pituitary Cells and Pituitary Neuroendocrine Tumor Cells.
Oh JY; Osorio RC; Jung J; Carrete L; Choudhary N; Lad M; Saha A; Aghi MK
Cancers (Basel); 2022 Dec; 15(1):. PubMed ID: 36612109
[TBL] [Abstract][Full Text] [Related]
22. [New pathological classification and clinical implications of pituitary neuroendocrine tumors of the 2022 WHO version].
Xie J; Wu ZB
Zhonghua Yi Xue Za Zhi; 2022 Dec; 102(47):3723-3726. PubMed ID: 36517420
[TBL] [Abstract][Full Text] [Related]
23. Mixed Sparsely Granulated Lactotroph and Densely Granulated Somatotroph Pituitary Neuroendocrine Tumor Expands the Spectrum of Neuroendocrine Neoplasms in Ovarian Teratomas: the Role of Pituitary Neuroendocrine Cell Lineage Biomarkers.
Hodgson A; Pakbaz S; Shenouda C; Francis JA; Mete O
Endocr Pathol; 2020 Sep; 31(3):315-319. PubMed ID: 32632841
[No Abstract] [Full Text] [Related]
24. Analysis of Insulinoma-Associated Protein 1 Expression in Pituitary Neuroendocrine Tumors.
Hirokawa Y; Inomoto C; Oyama K; Tahara S; Y Osamura R; Shiomi T; Matsuno A
Acta Histochem Cytochem; 2023 Dec; 56(6):105-110. PubMed ID: 38318099
[TBL] [Abstract][Full Text] [Related]
25. Transcriptomic analysis identifies a tumor subtype mRNA classifier for invasive non-functioning pituitary neuroendocrine tumor diagnostics.
Bao X; Wang G; Yu S; Sun J; He L; Zhao H; Ma Y; Wang F; Wang X; Wang R; Yu J
Theranostics; 2021; 11(1):132-146. PubMed ID: 33391466
[No Abstract] [Full Text] [Related]
26. DNA methylation-based signatures classify sporadic pituitary tumors according to clinicopathological features.
Mosella MS; Sabedot TS; Silva TC; Malta TM; Dezem FS; Asmaro KP; Wells M; Mukherjee A; Poisson LM; Snyder J; deCarvalho AC; Walbert T; Aho T; Kalkanis S; Elias PC; Antonini SR; Rock J; Noushmehr H; Castro M; Castro AV
Neuro Oncol; 2021 Aug; 23(8):1292-1303. PubMed ID: 33631002
[TBL] [Abstract][Full Text] [Related]
27. Single-cell sequencing identifies differentiation-related markers for molecular classification and recurrence prediction of PitNET.
Zhang Q; Yao B; Long X; Chen Z; He M; Wu Y; Qiao N; Ma Z; Ye Z; Zhang Y; Yao S; Wang Y; Cheng H; Chen H; Ye H; Wang Y; Li Y; Chen J; Zhang Z; Guo F; Zhao Y
Cell Rep Med; 2023 Feb; 4(2):100934. PubMed ID: 36754052
[TBL] [Abstract][Full Text] [Related]
28. Neuropathology of Pituitary Adenomas and Sellar Lesions.
Kobalka PJ; Huntoon K; Becker AP
Neurosurgery; 2021 Apr; 88(5):900-918. PubMed ID: 33476394
[TBL] [Abstract][Full Text] [Related]
29. Integrated proteogenomic characterization across major histological types of pituitary neuroendocrine tumors.
Zhang F; Zhang Q; Zhu J; Yao B; Ma C; Qiao N; He S; Ye Z; Wang Y; Han R; Feng J; Wang Y; Qin Z; Ma Z; Li K; Zhang Y; Tian S; Chen Z; Tan S; Wu Y; Ran P; Wang Y; Ding C; Zhao Y
Cell Res; 2022 Dec; 32(12):1047-1067. PubMed ID: 36307579
[TBL] [Abstract][Full Text] [Related]
30. Genomic and transcriptomic analysis of pituitary adenomas reveals the impacts of copy number variations on gene expression and clinical prognosis among prolactin-secreting subtype.
Chen Y; Gao H; Xie W; Guo J; Fang Q; Zhao P; Liu C; Zhu H; Wang Z; Wang J; Gui S; Zhang Y; Li C
Aging (Albany NY); 2020 Dec; 13(1):1276-1293. PubMed ID: 33472173
[TBL] [Abstract][Full Text] [Related]
31. Detection of tumor-specific DNA methylation markers in the blood of patients with pituitary neuroendocrine tumors.
Herrgott GA; Asmaro KP; Wells M; Sabedot TS; Malta TM; Mosella MS; Nelson K; Scarpace L; Barnholtz-Sloan JS; Sloan AE; Selman WR; deCarvalho AC; Poisson LM; Mukherjee A; Robin AM; Lee IY; Snyder J; Walbert T; Rosenblum M; Mikkelsen T; Bhan A; Craig J; Kalkanis S; Rock J; Noushmehr H; Castro AV
Neuro Oncol; 2022 Jul; 24(7):1126-1139. PubMed ID: 35212383
[TBL] [Abstract][Full Text] [Related]
32. PITX2 Expression in Non-functional Pituitary Neuroendocrine Tumor with Cavernous Sinus Invasion.
Tamura R; Ohara K; Morimoto Y; Kosugi K; Oishi Y; Sato M; Yoshida K; Toda M
Endocr Pathol; 2019 Jun; 30(2):81-89. PubMed ID: 30903445
[TBL] [Abstract][Full Text] [Related]
33. [Neuroimaging of Pituitary Neuroendocrine Tumors].
Kurosaki M
No Shinkei Geka; 2023 Jul; 51(4):634-641. PubMed ID: 37491060
[TBL] [Abstract][Full Text] [Related]
34. Gonadotroph-lactotroph associations and expression of prolactin receptors in the equine pituitary gland throughout the seasonal reproductive cycle.
Gregory SJ; Brooks J; McNeilly AS; Ingleton PM; Tortonese DJ
J Reprod Fertil; 2000 Jul; 119(2):223-31. PubMed ID: 10864834
[TBL] [Abstract][Full Text] [Related]
35. Past, Present, and Future of Therapies for Pituitary Neuroendocrine Tumors: Need for Omics and Drug Repositioning Guidance.
Aydin B; Yildirim E; Erdogan O; Arga KY; Yilmaz BK; Bozkurt SU; Bayrakli F; Turanli B
OMICS; 2022 Mar; 26(3):115-129. PubMed ID: 35172108
[TBL] [Abstract][Full Text] [Related]
36. Immunolocalization of Pit-1 in gonadotroph nuclei is indicative of the transdifferentiation of gonadotroph to lactotroph cells in prolactinomas induced by estrogen.
Mukdsi JH; De Paul AL; Muñoz S; Aoki A; Torres AI
Histochem Cell Biol; 2004 Jun; 121(6):453-62. PubMed ID: 15221415
[TBL] [Abstract][Full Text] [Related]
37. Single-cell transcriptome and genome analysis: A much-needed tool for pituitary neuroendocrine tumor studies.
Asa SL; Mete O
Neuro Oncol; 2021 Nov; 23(11):1803-1804. PubMed ID: 34480475
[No Abstract] [Full Text] [Related]
38. Primary Cilia as a Tumor Marker in Pituitary Neuroendocrine Tumors.
Martínez-Hernández R; Serrano-Somavilla A; Fernández-Contreras R; Sanchez-Guerrero C; Sánchez de la Blanca N; Sacristán-Gómez P; Sebastian-Valles F; Sampedro-Núñez M; Fraga J; Calatayud M; Vicente A; García-de-Casasola G; Sanz-García A; Araujo-Castro M; Ruz-Caracuel I; Puig-Domingo M; Marazuela M
Mod Pathol; 2024 May; 37(5):100475. PubMed ID: 38508520
[TBL] [Abstract][Full Text] [Related]
39. Aggressive nonfunctioning pituitary neuroendocrine tumors.
Portovedo S; Neto LV; Soares P; Carvalho DP; Takiya CM; Miranda-Alves L
Brain Tumor Pathol; 2022 Oct; 39(4):183-199. PubMed ID: 35725837
[TBL] [Abstract][Full Text] [Related]
40. Differential Expression of HMGA1 and HMGA2 in pituitary neuroendocrine tumors.
Portovedo S; Gaido N; de Almeida Nunes B; Nascimento AG; Rocha A; Magalhães M; Nascimento GC; Pires de Carvalho D; Soares P; Takiya C; Faria MDS; Miranda-Alves L
Mol Cell Endocrinol; 2019 Jun; 490():80-87. PubMed ID: 30999005
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
